Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia
Paul W. Ladenson(Johns Hopkins Medicine), Bo Angelin(Karolinska University Hospital), Jens D. Kristensen(Karo Pharma (Sweden)), John D. Baxter(Houston Methodist), E. Chester Ridgway(Boston University), Anders Olsson(Linköping University), Irwin Klein(Feinstein Institute for Medical Research), Bo Carlsson(Karo Pharma (Sweden))
Cited by 334
Related Papers
The Colorado Thyroid Disease Prevalence Study
|Archives of Internal Medicine|2000|2.8k
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
|New England Journal of Medicine|2012|2k
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
|The Lancet|2014|750
A Comparison of Recombinant Human Thyrotropin and Thyroid Hormone Withdrawal for the Detection of Thyroid Remnant or Cancer1
|The Journal of Clinical Endocrinology & Metabolism|1999|564
Subclinical Hypothyroidism Is Mild Thyroid Failure and Should be Treated
|The Journal of Clinical Endocrinology & Metabolism|2001|382